Health Care/Hospital News & Press Release Distribution

Nature Biotechnology | Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks

* First-in-Class Evaluation of an AI-Driven Candidate: This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models and Hallmarks of Aging Assessment). * First Universal Consensus Across Six Independently-De...

2026-09-07 17:42 1901

AXA launches GBA EverGuard Medical Insurance meeting rising demand for cross-border healthcare

Delivers 100% full cover in Chinese mainland, Greater China flexibility for designated illnesses or major surgeries, and enhanced Traditional Chinese Medicine treatments and rehabilitation support HONG KONG, Sept. 7, 2026 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") today announced the launch...

2026-09-07 17:36 1245

CelluPro Receives EXCiPACT™ Certification for GMP-grade Cell Culture Media Manufacturing, Strengthening Global Biomanufacturing Supply Capabilities

YANTAI, China, Sept. 7, 2026 /PRNewswire/ -- CelluPro, a biotechnology company specializing in serum-free cell culture media and bioprocess solutions, has achievedEXCiPACT™ GMP Certification for Pharmaceutical Auxiliary Materials (PAMs), becoming the first Chinese cell culture media supplier to r...

2026-09-07 14:00 1377

Prof Kevin Plaxco joins Nutromics as Chief Scientific Officer, bolstering expansion efforts for the DNA-based sensing platform

MELBOURNE, Australia, Sept. 7, 2026 /PRNewswire/ -- Nutromics, a Melbourne-based startup leading the frontier of DNA-based sensing, has announced the appointment of Professor Kevin W. Plaxco as Chief Scientific Officer (CSO). The company is preparing for the launch of its first product in 2027, ...

2026-09-07 13:14 1903

Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research

SEONGNAM, South Korea, Sept. 6, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced a major breakthrough in the high-efficiency production of circular RNA (circRNA) – a rapidly emerging modality ...

2026-09-07 12:36 1354

Ascletis Announces Inclusion in the Hong Kong Stock Connect List under the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect Programs

HONG KONG, Sept. 7, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that, the ordinary shares of the Company (the "Shares"), which trade on The Stock Exchange of Hong Kong Limited (the "HK Stock Exchange"), have been included in the list of eligible securities under t...

2026-09-07 12:15 2236

Ddrops® Brings Medical Experts from Damansara Specialist Hospital and Motherhood.com.my Together in Malaysia for Science-Backed Vitamin D Forum

KUALA LUMPUR, Malaysia, Sept. 7, 2026 /PRNewswire/ -- Ddrops® brought together Damansara Specialist Hospital , recognised among the World's Best Hospitals (2026) powered by Statista, and Motherhood.com.my

2026-09-07 12:00 2349

Ddrops® Brings Medical Experts from Damansara Specialist Hospital and Motherhood.com.my Together in Malaysia for Science-Backed Vitamin D Forum

AIA Australia, Long Service Corporation, New Zealand Police and RMBL Investments Named 2026 Appian APJ Innovation Award Winners

Four organisations recognised for transforming mission-critical operations through process and AI SYDNEY, Sept. 7, 2026 /PRNewswire/ -- Appian [Nasdaq: APPN] today announced AIA Australia, Long Service Corporation New South Wales (NSW), New Zealand Policeand RMBL Investments as the winners of it...

2026-09-07 11:28 5315

AIA Australia, Long Service Corporation, New Zealand Police and RMBL Investments Named 2026 Appian APJ Innovation Award Winners

Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction

Interim MASTRR Registry analysis represents, to Aroa's knowledge, the largest published prospective bioscaffold analysis in in-patient soft tissue reconstruction AUCKLAND, New Zealand, Sept. 6, 2026 /PRNewswire/ -- Aroa Biosurgery Limited (ASX: ARX), a soft tissue regeneration company, today ann...

2026-09-07 08:46 1773

CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients

- First to demonstrate clinical utility of ring-type BP monitoring in AF and heart failure patients - Highlighted CART blood pressure monitor's multifaceted value, including ESH-based validation and sleep apnea tracking MUNICH and SEOUL, South Korea, Sept. 7, 2026 /PRNewswire/ -- Sky Labs (CEO J...

2026-09-07 08:00 1321

CART Blood Pressure Monitor Demonstrates Utility in BP Monitoring for AF and Heart Failure Patients

Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults

-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection -- -- Robust neutralizing a...

2026-09-07 07:07 2093

Fosun Pharma Announces H-Share Repurchase Plan of Up to HK$ 1 Billion

SHANGHAI, Sept. 6, 2026 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) today announced an H-share repurchase plan, under which the company intends to repurchase its H-shares with an aggregate amount of up to HK$1 billion. The share...

2026-09-07 07:00 3807

FDI World Dental Federation launches Generation Smile, the oral health movement for all

Generation Smile is a generation unlike any other. It isn't defined by the year you were born. It unites people of every age, background and culture around one shared purpose: making oral health a priority because it is essential to health and well-being– for everyone, everywhere. - Picture is ...

2026-09-06 21:30 1600

Amwell Receives Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition for Technology-Enabled Care Platforms

Amwell® is transforming virtual care delivery through its unified Amwell Platform, combining interoperability, clinical integration, and intelligent orchestration to improve access, efficiency, and outcomes. SAN ANTONIO, Sept. 5, 2026 /PRNewswire/ -- As healthcare organizations move beyond fragm...

2026-09-05 08:53 2149

Italy is participating to the 26th China International Fair for Investment and Trade (CIFIT) which opens in Xiamen from 8-11 Sept.

ROME and XIAMEN, China, Sept. 4, 2026 /PRNewswire/ -- Curated by the Italian Trade Agency (ITA), in collaboration with the Ministry of Enterprises and Made in Italy (MIMIT), the Official Italian Pavilion is being unveiled at CIFIT in Xiamen. Italy is exhibiting at this edition of the main Investm...

2026-09-04 19:48 3799

Italy is participating to the 26th China International Fair for Investment and Trade (CIFIT) which opens in Xiamen from 8-11 Sept.

HoneyNaps Develops Next-Generation Wireless PSG system Using Four Skin Patches

* Patch-based wireless sensors and AI-powered analysis combine to improve patient comfort and clinical efficiency in polysomnography * New platform reduces more than 24 wired sensors to four compact patches, with potential applications in hospitals, home sleep testing and remote monitoring ...

2026-09-04 19:00 2679

HoneyNaps Develops Next-Generation Wireless PSG system Using Four Skin Patches

DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES

* Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility of A$10 million[2] * Facility terms for all Lenders substantially consistent with the p...

2026-09-04 19:00 3353

Acepodia Announces FDA Clearance of IND Application for ACE723, a Novel Dual-Payload Antibody-Drug Conjugate

FDA clearance enables initiation of a Phase 1 clinical trial and advances the first AD2C-generated candidate into clinical development ALAMEDA, Calif. and TAIPEI, Sept. 4, 2026 /PRNewswire/ -- Acepodia (6976: TT), a clinical-stage biotechnology company developing next-generation cell therapies a...

2026-09-04 19:00 2274

DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES

* Dimerix successfully enters into non-dilutive facility agreements to access A$34 million[1] with a syndicate of Australian and U.S. independent lenders, including the previously announced initial facility of A$10 million[2] * Facility terms for all Lenders substantially consistent with the p...

2026-09-04 11:00 3315

Carestream Healthcare International Enhances DRX‑LC Detector to Level Up Long‑Length Imaging Performance

SHANGHAI, Sept. 4, 2026 /PRNewswire/ -- Carestream Healthcare International is introducing the latest version of its DRX‑LC Detector, delivering enhanced imaging performance, efficiency, and quality for long‑length imaging across a wide range of exams and clinical environments.

2026-09-04 10:00 2639